Latest Articles

Beyond High-Risk: Expanding RSV Protection for Newborns and Infants

Infectious Disease During Mass Gathering

Loss of Smell Improvement in Patients With CRSwNP

New horizon of RSV lower respiratory tract disease LRTD in infants: Reflection on two seasons of prevention

VESTIGE Trial Results: Dupilumab in Type 2 Asthma

EPOS2020/EUFOREA Expert Opinion on Defining Disease States and Therapeutic Goals in CRSwNP

An expert panel convened by EPOS2020 and EUFOREA proposed standardized definitions for disease control, remission, and progression in CRSwNP. This initiative aims to harmonize and optimize the standard of care for patients with CRSwNP.

Between The Lines: GVHD, Episode 1 – Understanding the Foundation of Graft vs Host Disease

Tandem Meetings Transplantation and Cellular Therapy Meetings of ASTCT® and CIBMTR®

The Congress Connection: cGvHD and Transplant Key Takeaways in 2025

IL-4 and IL-13 are key and central cytokines with unique and overlapping roles contributing to the pathophysiology of CRSwNP